Clearside Biomedical, Inc.
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase 1/2a clinical trial; and CLS-301, an integrin inhibitor suspension for the treatment of diabetic macular edema and macular degeneration. The company has a collaboration with Bausch Health, Arctic Vision, REGENXBIO, Inc., and Aura Biosciences. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia. Show More...
-
Website https://www.clearsidebio.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 0.76 USD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD -0.59 -0.83 -1.44 -1.97 -2.33 -2.69 -0.81 -0.43 Dividends USD Payout Ratio % * Shares Mil 12.0 12.0 12.0 13.0 25.0 31.0 38.0 41.0 Book Value Per Share * USD 1.91 1.46 1.37 0.22 0.19 Free Cash Flow Per Share * USD -0.98 -1.77 -2.41 -1.49 Return on Assets % -339.45 -163.86 -112.52 -48.89 -94.13 -195.76 -86.8 -58.41 Financial Leverage (Average) 1.18 1.89 1.87 2.4 2.4 Return on Equity % -147.9 -126.73 -367.79 -176.96 -137.78 Return on Invested Capital % -110.54 -105.44 -262.84 -120.29 -82.01 Interest Coverage -314.39 -26.46 -52.45 Current Ratio 2.95 3.43 3.94 15.59 2.9 4.1 2.31 1.71 Quick Ratio 2.79 3.41 3.9 15.46 2.78 3.9 2.07 1.52 Debt/Equity 0.11 0.22 0.4 0.42 0.08